Melbourne Health, Royal Melbourne Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sasadeusz, Joe
ACTRN12608000400369: A single-arm, open-label, pilot study evaluating the efficacy and safety of directly observed peginterferon alfa-2a with ribavirin in conjunction with a peer counsellor in patients actively using injecting drugs who have chronic hepatitis C and attend a drug and alcohol centre.

Recruiting
4
50
 
Dr Joe Sasadeusz, Roche Products Pty Ltd
Impact of standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection on: (i) quality of life, (ii) mental health status, (iii) injecting drug behaviours, and (iv) opioid pharmacotherapy use in active injecting drug users (IDUs)., Side effects related to chronic Hepatitis C virus (HCV) infection and treatment in active injecting drug users (IDUs)., Factors affecting compliance of active injecting drug users (IDUs) for standard pharmacotherapy treatment of chronic Hepatitis C virus (HCV) infection., Chronic hepatitis C virus (HCV) infection.
 
 
NCT05477186: Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Completed
1
180
US, RoW
CV0501 (3 μg), CV0501 (6 μg), CV0501 (12 μg), CV0501 (25 μg), CV0501 (50 μg), CV0501 (75 μg), CV0501 (100 μg), CV0501 (150 μg), CV0501 (200 μg)
GlaxoSmithKline
COVID-19, SARS-CoV-2
08/23
08/23
COMMIT, NCT03645044: Towards a Functional Cure for HBV - The Cohort Study

Active, not recruiting
N/A
102
RoW
University of Melbourne, National Health and Medical Research Council, Australia, The University of Western Australia, University of Adelaide, The HIV Netherlands Australia Thailand Research Collaboration, University of Malaya, YR Gaitonde Centre for AIDS Research and Education, Melbourne Health
Hiv, HBV Coinfection
04/22
12/24
ACTRN12605000682640: A single-arm, open-label, multi-centre pilot study evaluating the efficacy and safety of Ro 25-8310 combination therapy with Ro 20-9963 in pateints with chronic hepatitis C attending a methdone clinic

Recruiting
N/A
50
 
Melbourne Health, Melbourne Health
Chronic hepatitis C
 
 
ACTRN12605000645651: HPV infection and cervial dysplasia in bone marrow transplant recipients

Recruiting
N/A
82
 
Melbourne Health, Investigator
Bone Marrow Transplant
 
 

Download Options